Literature DB >> 6690287

Cortisol decreases bone formation by inhibiting periosteal cell proliferation.

Y S Chyun, B E Kream, L G Raisz.   

Abstract

We tested the hypothesis that the inhibitory effect of cortisol on bone growth is primarily on the periosteum. Fetal rat calvaria were maintained in organ culture, labeled with radioactive proline or thymidine, and then dissected to separate periosteum from the osteoblast-rich central bone. There was a dose- and time-dependent inhibition of thymidine incorporation into DNA in the periosteum which was significant at 24 h. These observations were further supported by decreases in the dry weight and DNA content of the periosteum at 96 h. Incorporation of thymidine and proline into the central bone were decreased only at 96 h. Pulse-chase studies using a high concentration of cortisol (10(-6) M) indicated that increased cell attrition may also play a role in the inhibitory effect of cortisol. We propose that the primary effect of cortisol on bone growth is an inhibition of proliferation of the periosteal cells which give rise to osteoblasts. The subsequent decrease in the incorporation of proline into the central bone may be the consequence of this inhibition.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690287     DOI: 10.1210/endo-114-2-477

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

Review 1.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Optimizing bone health in anorexia nervosa and hypothalamic amenorrhea: new trials and tribulations.

Authors:  Joo-Pin Foo; Ole-Petter R Hamnvik; Christos S Mantzoros
Journal:  Metabolism       Date:  2012-01-31       Impact factor: 8.694

3.  The role of glucocorticoids and prostaglandin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects.

Authors:  A Scutt; P Bertram; M Bräutigam
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 4.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

5.  Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations.

Authors:  C G Bellows; J E Aubin; J N Heersche; M E Antosz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

6.  Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats.

Authors:  C Maniatopoulos; J Sodek; A H Melcher
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

7.  Post-traumatic stress disorder and incident fractures in the Danish population.

Authors:  T Jiang; K Veres; D Körmendiné Farkas; T L Lash; H T Sørensen; J L Gradus
Journal:  Osteoporos Int       Date:  2018-08-20       Impact factor: 4.507

8.  Effect of low-dose methylprednisolone on calcium balance and bone composition in rats.

Authors:  A Voulgaris; C Liapi; J Papadopoulos
Journal:  J Endocrinol Invest       Date:  1997-12       Impact factor: 4.256

9.  Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats.

Authors:  R T Turner; K S Hannon; V S Greene; N H Bell
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

10.  Recombinant human growth hormone overcomes the growth-suppressive effect of methylprednisolone in uraemic rats.

Authors:  G Kovàcs; R N Fine; S Worgall; F Schaefer; E B Hunziker; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.